Related Experiment Video
Updated: Aug 9, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Comorbidities, multimorbidity and COVID-19
Clark D Russell1, Nazir I Lone2,3, J Kenneth Baillie4,5,6
1Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK.
Insights
Comorbidities significantly impact COVID-19 outcomes by worsening disease progression through distinct pathological mechanisms. Host genetics may offer causal insights, aiding targeted therapies for better patient results.
Area of Science:
- Infectious Diseases
- Immunology
- Genetics
Background:
- Comorbidities have long been linked to severe COVID-19 outcomes.
- Establishing causal links and mechanisms is complex due to confounding factors and patient variability.
- COVID-19 progresses through distinct phases, each with unique pathological mechanisms influenced by comorbidities.
Purpose of the Study:
- To review the impact of comorbidities and multimorbidity on the three distinct phases of COVID-19.
- To explore the role of host genetics in understanding causal inference for COVID-19 outcomes.
- To discuss clinical implications for therapeutic strategies.
Main Methods:
- Literature review focusing on comorbidities, multimorbidity, and COVID-19 pathogenesis.
- Analysis of pathological mechanisms across COVID-19 phases.
- Discussion of host genetics as a tool for causal inference.
Main Results:
- Specific comorbidities can exacerbate COVID-19 pathological mechanisms or reduce organ injury tolerance.
- Multimorbidity presents a complex challenge in predicting COVID-19 severity.
- Host genetics offers a potential method to mitigate confounding factors in outcome research.
Conclusions:
- Understanding disease-state interactions is critical for stratifying treatments.
- Host genetics can elucidate causal relationships between comorbidities and COVID-19.
- Further research is needed to refine therapeutic approaches and improve patient outcomes in COVID-19.
Abstract:
The influence of comorbidities on COVID-19 outcomes has been recognized since the earliest days of the pandemic. But establishing causality and determining underlying mechanisms and clinical implications has been challenging-owing to the multitude of confounding factors and patient variability. Several distinct pathological mechanisms, not active in every patient, determine health outcomes in the three different phases of COVID-19-from the initial viral replication phase to inflammatory lung injury and post-acute sequelae. Specific comorbidities (and overall multimorbidity) can either exacerbate these pathological mechanisms or reduce the patient's tolerance to organ injury. In this Review, we consider the impact of specific comorbidities, and overall multimorbidity, on the three mechanistically distinct phases of COVID-19, and we discuss the utility of host genetics as a route to causal inference by eliminating many sources of confounding. Continued research into the mechanisms of disease-state interactions will be crucial to inform stratification of therapeutic approaches and improve outcomes for patients.
Related Concept Videos
Factors Affecting Illness
For instance, risk factors are connected to illness,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Causality in Epidemiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

